Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0291
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2009
Authors
Publisher
American Association for Cancer Research (AACR)